Contributions
Abstract: EP1378
Type: ePoster
Abstract Category: Clinical aspects of MS - MS symptoms
Background: Studies of psychiatric comorbidities in multiple sclerosis (MS) patients have reported higher rates in MS patients than the general population.
Objectives: To assess symptoms of attention-deficit/hyperactivity disorder (ADHD) and their impact in adults with multiple sclerosis.
Methods: Subjects consisted of 72 Relapsing Remitting MS patients and 57 controls. Demographic characteristics including age, gender, education level, disease duration and Expanded Disability Symptom Scale (EDSS) were recorded. ADHD symptoms were assessed by Adult Attention Deficit/Hyperactivity Disorder Self-Report Scale (ASRS). Additionally, Short Form-36 (SF-36) and Hospital Anxiety and Depression Scale (HADS) were also performed.
Results: Patients with MS had significantly higher the rate of ADHD mean scores compared to controls. MS patients had significantly higher rate of clinical elevation in ASRS scores. There were 26 MS patients and 4 controls with ADHD symptoms. ASRS scores in MS patients were associated with anxiety and depression scores and SF-36 physical and mental component scores in bivariate analyses.
Conclusion: Attention Deficit/Hyperactivity Disorder symptoms may develope in adults with MS and are associated with increased psychosocial morbidity and lowered quality of life. Future and more comprehensive studies could clarify causes of ADHD symptoms in adults with MS.
Disclosure: There is no conflicts of interest.
Abstract: EP1378
Type: ePoster
Abstract Category: Clinical aspects of MS - MS symptoms
Background: Studies of psychiatric comorbidities in multiple sclerosis (MS) patients have reported higher rates in MS patients than the general population.
Objectives: To assess symptoms of attention-deficit/hyperactivity disorder (ADHD) and their impact in adults with multiple sclerosis.
Methods: Subjects consisted of 72 Relapsing Remitting MS patients and 57 controls. Demographic characteristics including age, gender, education level, disease duration and Expanded Disability Symptom Scale (EDSS) were recorded. ADHD symptoms were assessed by Adult Attention Deficit/Hyperactivity Disorder Self-Report Scale (ASRS). Additionally, Short Form-36 (SF-36) and Hospital Anxiety and Depression Scale (HADS) were also performed.
Results: Patients with MS had significantly higher the rate of ADHD mean scores compared to controls. MS patients had significantly higher rate of clinical elevation in ASRS scores. There were 26 MS patients and 4 controls with ADHD symptoms. ASRS scores in MS patients were associated with anxiety and depression scores and SF-36 physical and mental component scores in bivariate analyses.
Conclusion: Attention Deficit/Hyperactivity Disorder symptoms may develope in adults with MS and are associated with increased psychosocial morbidity and lowered quality of life. Future and more comprehensive studies could clarify causes of ADHD symptoms in adults with MS.
Disclosure: There is no conflicts of interest.